Bertrand raises slippery slopes, but the history of marrow and corneas makes the argument less tidy. U.S. law has already allowed some compensated marrow donation and once tolerated aggressive cornea procurement before public controversy helped push the law back. Slopes can reverse. buff.ly/PYsKehB
A recent survey of economists by the Clark Center for Global Markets at Chicago Booth offers a useful snapshot of how economists think about living-donor kidney transplantation — and, more…
